Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s ...
MIAMI, Oct. 09, 2025 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or the “Company”), a clinical-stage biotechnology company developing therapies for Alzheimer’s disease and other ...
What a major US study really found about longevity, heart disease, and cancerAmericans often wonder: Does eating more protein, whether from meat, dairy, or plants, raise your risk of dying early from ...
World-renowned longevity physician to help guide Klothea Bio as it prepares for a Phase 1B clinical trial of its Klotho therapeutic for aging related diseases ...